Hannah Corsi

University of South Carolina '20

[Hannah Corsi @hannahcorsi]

MEK inhibitors target a common biochemical signaling pathway studied in cancer genetics. It has been studied as a potential cancer therapy, and it was found that they could dramatically affect the size of NF1 tumors by blocking cofactor-ligand connection.

[Labroots Genetics @Genetics_LR]

For the First Time, Neurofibromatosis 1 Patients Will Have a Treatment Option | A new drug successfully reduced the size of tumors in a majority of NF1 patients in the clinical trial.https://t.co/OCW0IQ4DOC

[Hannah Corsi @hannahcorsi]

@ScienceNews The most important question is, are these drugs worth it? or should global efforts be focused on vaccine development. Prevention vs. treatment is the underlying debate.

[NASA's Johnson Space Center @NASAJohnson]

As we look forward to the future, we reflect and remember those who secured it for us by making the ultimate sacrifice. #MemorialDay